Product approval information is indicated for adults and children with Hemophilia A for (1) on-demand treatment and control of bleeding episodes, (2) perioperative management, and (3) routine prophylaxis to prevent or reduce the frequency of bleeding episodes.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2lAiR9F
No comments:
Post a Comment